These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
178 related items for PubMed ID: 8325116
1. Relative release of interleukin-1 beta and interleukin-1 receptor antagonist by alveolar macrophages. A study in asbestos-induced lung disease, sarcoidosis, and idiopathic pulmonary fibrosis. Kline JN, Schwartz DA, Monick MM, Floerchinger CS, Hunninghake GW. Chest; 1993 Jul; 104(1):47-53. PubMed ID: 8325116 [Abstract] [Full Text] [Related]
2. Enhanced production of IL-1 receptor antagonist by alveolar macrophages from patients with interstitial lung disease. Janson RW, King TE, Hance KR, Arend WP. Am Rev Respir Dis; 1993 Aug; 148(2):495-503. PubMed ID: 8342915 [Abstract] [Full Text] [Related]
3. Quantitative evaluation of the IL-1 beta and IL-1 receptor antagonist obtained from BALF macrophages in patients with interstitial lung diseases. Mikuniya T, Nagai S, Shimoji T, Takeuchi M, Morita K, Mio T, Satake N, Izumi T. Sarcoidosis Vasc Diffuse Lung Dis; 1997 Mar; 14(1):39-45. PubMed ID: 9186988 [Abstract] [Full Text] [Related]
8. Enhanced IL-1 beta and tumor necrosis factor-alpha release and messenger RNA expression in macrophages from idiopathic pulmonary fibrosis or after asbestos exposure. Zhang Y, Lee TC, Guillemin B, Yu MC, Rom WN. J Immunol; 1993 May 01; 150(9):4188-96. PubMed ID: 8473757 [Abstract] [Full Text] [Related]
11. Alveolar macrophage cytokine and growth factor production in a rat model of crocidolite-induced pulmonary inflammation and fibrosis. Driscoll KE, Maurer JK, Higgins J, Poynter J. J Toxicol Environ Health; 1995 Oct 01; 46(2):155-69. PubMed ID: 7563215 [Abstract] [Full Text] [Related]
12. Suppressive mechanisms of alveolar macrophages in interstitial lung diseases: role of soluble factors and cell-to-cell contact. Fireman E, Ben-Efraim S, Spinrad S, Topilsky M, Greif J. Eur Respir J; 1993 Jul 01; 6(7):956-64. PubMed ID: 8370444 [Abstract] [Full Text] [Related]
13. Increased number of alveolar macrophages expressing surface molecules of the CD11/CD18 family in sarcoidosis and idiopathic pulmonary fibrosis is related to the production of superoxide anions by these cells. Schaberg T, Rau M, Stephan H, Lode H. Am Rev Respir Dis; 1993 Jun 01; 147(6 Pt 1):1507-13. PubMed ID: 8099261 [Abstract] [Full Text] [Related]
14. Increased interleukin-1 receptor antagonist in idiopathic pulmonary fibrosis. A compartmental analysis. Smith DR, Kunkel SL, Standiford TJ, Rolfe MW, Lynch JP, Arenberg DA, Wilke CA, Burdick MD, Martinez FJ, Hampton JN. Am J Respir Crit Care Med; 1995 Jun 01; 151(6):1965-73. PubMed ID: 7767546 [Abstract] [Full Text] [Related]
15. Multinuclear giant cells in bronchoalveolar lavage in interstitial lung diseases. Agustí C, Xaubet A, Arriols R, Marín A, Montserrat JM, Agustí-Vidal A. Respiration; 1987 Jun 01; 51(4):307-11. PubMed ID: 3659580 [Abstract] [Full Text] [Related]
16. Oxidized BAL fluid proteins in patients with interstitial lung diseases. Lenz AG, Costabel U, Maier KL. Eur Respir J; 1996 Feb 01; 9(2):307-12. PubMed ID: 8777969 [Abstract] [Full Text] [Related]